Grantopen🌐 United StatesRFA-HL-26-016

Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)

National Institutes of Health

Details?

Posted: Nov 22, 2024
Response deadline: Dec 23, 2027, 12:00 AM UTC (530d)
Type: Grant
Category: 93.839, 93.233, 93.838, 93.837
Status: open
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: RFA-HL-26-016

Doc Type: synopsis
Opp Status: posted

Similar open solicitations

Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
United States · Nov 22, 2024
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
United States · Dec 5, 2024
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
United States · Nov 14, 2024
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
United States · Dec 5, 2024
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
United States · Dec 31, 2024
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
United States · Nov 22, 2024

Similar past solicitations

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
United States · Dec 16, 2024
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
United States · Nov 14, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.